𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active-site conformation of 17-(3-pyridyl)androsta-5,16-dien-3β-ol, a potent inhibitor of the P450 enzyme C17α-hydroxylase/C17-20 lyase

✍ Scribed by David F. Burke; Charles A. Laughton; Chris F. Snook; Stephen Neidle; Gerard A. Potter; Michael Jarman


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
228 KB
Volume
5
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


17-(3-pyridyl)androsta-5,16-dien-3[~-ol, a nanomolar inhibitor of the P450 enzyme C17ct-hydroxylase/C17-20 lyase, is a target for prostate cancer chemotherapy. A model is presented for the inhibitor docked into the structure of the enzyme.


📜 SIMILAR VOLUMES


ChemInform Abstract: The 16,17-Double Bo
✍ Michael Jarman; S. Elaine Barrie; Jose M. Llera 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 40 KB 👁 1 views

The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P450 17α by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3β-ol) and Related Steroidal Inhibitors. -Investigation of the structural features required for irreversible binding of steroidal inhibitors, e.g. (I)-(VI), to th